Ambeed.cn

首页 / / / / IOX1

IOX1 {[allProObj[0].p_purity_real_show]}

货号:A170634 同义名: 5-羰基-8-羟基喹啉

IOX1是一种广谱的2OG氧化酶抑制剂,对于KDM4A/KDM3A和KDM4C/KDM6B/KDM2A/KDM4E的IC50分别为0.6/0.1 μM和0.6 μM/1.6 μM/1.8 μM/2.3 μM。

IOX1 化学结构 CAS号:5852-78-8
IOX1 化学结构
CAS号:5852-78-8
IOX1 3D分子结构
CAS号:5852-78-8
IOX1 化学结构 CAS号:5852-78-8
IOX1 3D分子结构 CAS号:5852-78-8
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

IOX1 纯度/质量文件 产品仅供科研

货号:A170634 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 KDM1 KDM2 KDM3 KDM4 KDM5 KDM6 其他靶点 纯度
OG-L002 +++

LSD1, IC50: 20 nM

99%+
ORY-1001 +++

LSD1, IC50: 20 nM

98%
SP-2509 ++++

LSD1, IC50: 13 nM

98+%
GSK2879552 2HCl +

LSD1, Ki: 1.7 μM

99%+
T-3775440 HCl ++++

LSD1, IC50: 2.1 nM

99%
GSK-LSD1 2HCl +++

LSD1, IC50: 16 nM

98%
Pulrodemstat benzenesulfonate 99%+
IOX1 +

KDM2A, IC50: 1.8 μM

+++

KDM3A, IC50: 0.1 μM

++

KDM4E, IC50: 2.3 μM

KDM4C, IC50: 0.6 μM

+

KDM5C, IC50: 19 μM

+

KDM6B, IC50: 1.6 μM

99%
PFI-90 99%+
ML324 +

JMJD2, IC50: 920 nM

99%+
NCGC00244536 ++++

KDM4, IC50: 10 nM

99%
KDM4D-IN-1 ++

KDM4D, IC50: 0.41 μM

99%+
GSK467 ++++

KDM5B, Ki: 10 nM

99%
GSK-J1 +++

JMJD3, IC50: 60 nM

99%+
(Z)-JIB-04 ++

JMJD2A, IC50: 1100 nM

JMJD2E, IC50: 340 nM

++

JARID1A, IC50: 230 nM

++

JMJD3, IC50: 855 nM

97%
CPI-455 ++++

KDM5A, IC50: 10 nM

++++

KDM5, IC50: 10 nM

98%
JIB-04 ++

JMJD2D, IC50: 290 nM

JMJD2E, IC50: 435 nM

++

JARID1A, IC50: 230 nM

++

JMJD3, IC50: 855 nM

98%
GSK-J4 HCl +++

JMJD3, IC50: 60 nM

98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

IOX1 生物活性

靶点
  • KDM2

    KDM2A, IC50:1.8 μM

  • KDM4

    KDM4E, IC50:2.3 μM

    KDM4C, IC50:0.6 μM

  • KDM6

    KDM6B, IC50:1.6 μM

  • KDM5

    KDM5C, IC50:19 μM

  • KDM3

    KDM3A, IC50:0.1 μM

描述 The Jumonji C domain (JmjC) demethylases belong to the superfamily of FeII and 2-oxoglutarate (2OG) oxygenases. IOX1 is a potent inhibitor against a broad-spectrum of 2OG oxygenases, including non-JmjC 2OG oxygenases, with in vitro IC50 values in the micromolar range. Treatment of HeLa cells with 300μM of IOX1 led to a dose-dependent increase in H3K9me3 fluorescence intensity compared to the DMSO-treated control group. The cellular EC50 value of IOX1 in HeLa cells was 100μM. The amplified luminescent proximity homogeneous assay revealed that the IC50 value of IOX1 for the inhibition of H3K9me3 demethylation activity of isolated KDM4C was 0.6μM. The IC50 values of IOX1 for KDM4E, KDM2A, KDM3A, KDM5C, KDM6B, and PHD2 were 2.3, 1.8, 0.1, 19.0, 1.4, and 33.0μM, respectively.[3] In immunocompetent C57BL/6 mice harboring B16F10 tumors with a volume of about 50 mm3, repetitive intraperitoneal administration of IOX1 (2.5mg/kg) every two days significantly attenuated melanoma expansion at 10 days after treatment.[4]
作用机制 IOX1 is a potent, broad-spectrum 2OG oxygenase inhibitor with low cell permeability due to its polar C-5 carboxyl group.[3]

IOX1 细胞实验

Cell Line
Concentration Treated Time Description References
AGS cells 5 μM 48 h IOX1 significantly increased the expression of IFN-stimulated genes (ISGs), such as CXCL10, ISG15 and IFNB1 Adv Sci (Weinh). 2024 Oct;11(40):e2309983.
MFC cells 5 μM 48 h IOX1 significantly increased the expression of IFN-stimulated genes (ISGs), such as CXCL10, ISG15 and IFNB1 Adv Sci (Weinh). 2024 Oct;11(40):e2309983.
Mouse keratinocytes 200 µM 24 h To study the effect of IOX-1 on IL-23A expression, results showed that IOX-1 significantly reduced IL-23A expression. Nat Commun. 2018 Apr 12;9(1):1420.
Human keratinocytes 200 µM 24 h To study the effect of IOX-1 on IL-23A expression, results showed that IOX-1 significantly reduced IL-23A expression. Nat Commun. 2018 Apr 12;9(1):1420.
CT26 cells 5, 25, 50 μM 24 h Inhibited P-gp expression and enhanced DOX cytotoxicity Nat Commun. 2021 Apr 23;12(1):2425.
HCT116 cells 5, 25, 50 μM 24 h Inhibited P-gp expression and enhanced DOX cytotoxicity Nat Commun. 2021 Apr 23;12(1):2425.
CT26 cells 25 μM 4 h Enhanced DOX-induced immunogenic cell death (ICD) Nat Commun. 2021 Apr 23;12(1):2425.
HEK293 cells 100 μM 24 h To evaluate the inhibitory effect of IOX1 on histone demethylation, results showed that IOX1 treatment significantly increased the levels of me3Lys and me2Lys. Anal Chem. 2017 Jan 17;89(2):1299-1306.
ESCC cells 50 µM 24 h IOX1 increased H3K9me2 levels and slightly altered H3K27me3 levels, while decreasing the protein expression of KDM3A and KDM6B. Cell Death Dis. 2020 Dec 14;11(12):1068.
ESCC cells 20 µM IOX1 decreased the survival fraction of all ESCC cells and increased sensitivity to radiotherapy. Cell Death Dis. 2020 Dec 14;11(12):1068.
Murine CD4+ T cells 10 μM and 20 μM 72 h To evaluate the effect of IOX1 on Th1 and Th17 cell differentiation, results showed that IOX1 significantly suppressed IL-17 expression but had less effect on IFN-γ expression EBioMedicine. 2022 Dec;86:104333.
Human peripheral blood CD4+ T cells 25 μM and 100 μM 5 days To evaluate the effect of IOX1 on human CD4+ T cell proliferation and differentiation, results showed that IOX1 dose-dependently suppressed IFN-γ and IL-17 expression EBioMedicine. 2022 Dec;86:104333.
A549 40 μM 48 h IOX1 significantly enhanced the radiosensitivity of A549 cells, significantly increasing γirradiation-induced apoptosis. Cell Death Dis. 2023 Dec 12;14(12):817.
H1299 40 μM 48 h IOX1 significantly enhanced the radiosensitivity of H1299 cells, significantly increasing γirradiation-induced apoptosis. Cell Death Dis. 2023 Dec 12;14(12):817.
H1975 40 μM 48 h IOX1 significantly enhanced the radiosensitivity of H1975 cells, significantly increasing γirradiation-induced apoptosis. Cell Death Dis. 2023 Dec 12;14(12):817.
HeLa 40 μM 48 h IOX1 significantly enhanced the radiosensitivity of HeLa cells, significantly increasing γirradiation-induced apoptosis. Cell Death Dis. 2023 Dec 12;14(12):817.

IOX1 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Mice Renal ischemia-reperfusion injury model Tail vein injection 10 mg/kg Single administration before surgery IOX1 alleviates renal ischemia-reperfusion injury by increasing m6A methylation and regulating the CCL28/Treg/inflammatory cell axis. Nat Commun. 2023 Mar 1;14(1):1161
Mice Subcutaneous xenograft model in nude mice Intraperitoneal injection 12.5 mg/kg Every 2 days, continued treatment IOX1 significantly suppressed tumor growth, decreased tumor volume, and reduced tumor weight Adv Sci (Weinh). 2024 Oct;11(40):e2309983.
BALB/c mice S.c. CT26 tumour model Intravenous injection 7.5 mg/kg Every 2 days for 3 times IPLD significantly inhibited tumour growth and induced immune memory Nat Commun. 2021 Apr 23;12(1):2425.
B10.RIII mice Experimental autoimmune uveoretinitis (EAU) model Intraperitoneal injection 12.5 mg/kg Twice daily, until peak disease (Day 14) To evaluate the effect of IOX1 on Th17 cell migration and inflammation in the EAU model, results showed that IOX1 significantly reduced the migration of Th17 cells into the site of inflammation and tissue damage EBioMedicine. 2022 Dec;86:104333.
Nude mice A549 xenograft model Injection 10 mg/kg Once a day for 6 days IOX1 significantly suppressed the growth of A549 tumors and enhanced the tumor's sensitivity to radiation. Cell Death Dis. 2023 Dec 12;14(12):817.

IOX1 动物研究

Dose Mice: 2.5 mg/kg[3] (i.p.)
Administration i.p.

IOX1 参考文献

[1]Hu Q, Chen J, et al. IOX1, a JMJD2A inhibitor, suppresses the proliferation and migration of vascular smooth muscle cells induced by angiotensin II by regulating the expression of cell cycle-related proteins. Int J Mol Med. 2016 Jan;37(1):189-96.

[2]Schiller R, Scozzafava G, et al. A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1. ChemMedChem. 2014 Mar;9(3):566-71.

[3]Schiller R, Scozzafava G, Tumber A, Wickens JR, Bush JT, Rai G, Lejeune C, Choi H, Yeh TL, Chan MC, Mott BT, McCullagh JS, Maloney DJ, Schofield CJ, Kawamura A. A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1. ChemMedChem. 2014 Mar;9(3):566-71

[4]Yu Y, Schleich K, Yue B, Ji S, Lohneis P, Kemper K, Silvis MR, Qutob N, van Rooijen E, Werner-Klein M, Li L, Dhawan D, Meierjohann S, Reimann M, Elkahloun A, Treitschke S, Dörken B, Speck C, Mallette FA, Zon LI, Holmen SL, Peeper DS, Samuels Y, Schmitt CA, Lee S. Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma. Cancer Cell. 2018 Feb 12;33(2):322-336.e8

IOX1 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.29mL

1.06mL

0.53mL

26.43mL

5.29mL

2.64mL

52.86mL

10.57mL

5.29mL

IOX1 技术信息

CAS号5852-78-8
分子式C10H7NO3
分子量 189.17
SMILES Code O=C(C1=C2C=CC=NC2=C(O)C=C1)O
MDL No. MFCD18417145
别名 5-羰基-8-羟基喹啉
运输蓝冰
InChI Key JGRPKOGHYBAVMW-UHFFFAOYSA-N
Pubchem ID 459617
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, 2-8°C

溶解方案

DMSO: 12 mg/mL(63.44 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。